Case Report

Published on 14 May 2024

Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab

in Cancer Immunity and Immunotherapy

Oskar Krueger
Robin Eisenburger
Alpaslan Tasdogan
Lisa Zimmer
Elisabeth Livingstone
Eva Hadaschik
Sarah Theurer
Berthold Brodin
Dirk Schadendorf
Selma Ugurel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369190

306 views

Review

Published on 14 May 2024

The role of E2F2 in cancer progression and its value as a therapeutic target

in Cancer Immunity and Immunotherapy

Yang Gao
Xinjie Qiao
Zhenhui Liu
Wenzhou Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397303

134 views

Original Research

Published on 14 May 2024

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

in Cancer Immunity and Immunotherapy

Edoardo Ruggeri
Federica Frezzato
Nayla Mouawad
Marco Pizzi
Federico Scarmozzino
Guido Capasso
Valentina Trimarco
Laura Quotti Tubi
Alessandro Cellini
Chiara Adele Cavarretta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393485

299 views

Original Research

Accepted on 13 May 2024

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes

in Cancer Immunity and Immunotherapy

Oscar Eduardo Molina
Hélène LaRue
David Simonyan
Hélène Hovington
Benjamin Vittrant
Bernard Têtu
Vincent Fradet
Louis Lacombe
Alain Bergeron
Yves Fradet

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372837

Original Research

Accepted on 13 May 2024

High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas

in Cancer Immunity and Immunotherapy

Abdou-Samad KONE
Amina GHOUZLANI
Ahmed QANDOUCI
Nour el Imane Issam SALAH
Yann BAKOUKOU
Abdelhakim LAKHDAR
Mehdi KARKOURI
Abdallah BADOU

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397486

Original Research

Accepted on 13 May 2024

Optimizing Immune Checkpoint Blockade in Metastatic Uveal Melanoma: Exploring the Association of Overall Survival and the Occurrence of Adverse Events

in Cancer Immunity and Immunotherapy

Elias A. T. Koch
Anne Petzold
Edgar Dippel
Michael Erdmann
Anja Gesierich
Ralf Gutzmer
Jessica Hassel
Sebastian Haferkamp
Katharina Kähler
Nicole Kreuzberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395225

Review

Accepted on 13 May 2024

Artificial Intelligence and Neoantigens: Paving the Path for Precision Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Alla Bulashevska
Zsófia Nacsa Nacsa
Franziska Lang
Markus Braun
Martin Machyna
Mustafa Diken
Liam Childs
Renate König

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394003

Case Report

Accepted on 13 May 2024

Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review

in Cancer Immunity and Immunotherapy

Haidong Ai
Ting Gong
Yongbiao Ma
Guixu Ma
Wei Ding
Weibao Ding
Wenjuan Wang
Xuelin Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1358602

Original Research

Accepted on 13 May 2024

Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Chen Ding
Hua Huang
Di Wu
Chen Chen
Yu Hua
Jinghao Liu
Yongwen Li
HONGYU LIU
Jun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369073

Review

Accepted on 13 May 2024

Advancements in Ovarian Cancer immunodiagnostics and Therapeutics via Phage Display Technology

in Cancer Immunity and Immunotherapy

Yang Li
Kai-Di Yang
Wei-Hua Tong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1402862

Review

Published on 13 May 2024

RNA m5C methylation: a potential modulator of innate immune pathways in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Sun Meng
Bai Jiangtao
Wang Haisong
Li Mei
Zhou Long
Li Shanfeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362159

Editorial

Published on 13 May 2024

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison

in Cancer Immunity and Immunotherapy

Jing Xu
Haitao Wang
Xiao Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1422624

162 views

Brief Research Report

Published on 13 May 2024

Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration

in Cancer Immunity and Immunotherapy

Edisa Pirani
Philipp Paparoditis
Matteo Pecoraro
Gabriela Danelon
Marcus Thelen
Valentina Cecchinato
Mariagrazia Uguccioni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1358800

226 views

Editorial

Published on 13 May 2024

Editorial: Targeting key cellular signaling network for cancer chemotherapy and immunotherapy

in Cancer Immunity and Immunotherapy

Wanshun Li
Xinyue Wang
Dongling Wan
Jiayu Li
Zhendong Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423917

113 views

Original Research

Published on 13 May 2024

Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer

in Cancer Immunity and Immunotherapy

Xiaoxi Han
Chuanyu Leng
Shufen Zhao
Shasha Wang
Shuming Chen
Shibo Wang
Mengqi Zhang
Xiangxue Li
Yangyang Lu
Bing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377472

146 views

Case Report

Published on 13 May 2024

Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission

in Cancer Immunity and Immunotherapy

Xiaojuan Miao
Yanrong Shuai
Ying Han
Nan Zhang
Yilan Liu
Hao Yao
Xiao Wang
Guangcui He
Dan Chen
Fangyi Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1389227

171 views

Navigation group

Articles

Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab

The role of E2F2 in cancer progression and its value as a therapeutic target

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes

High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas

Optimizing Immune Checkpoint Blockade in Metastatic Uveal Melanoma: Exploring the Association of Overall Survival and the Occurrence of Adverse Events

Artificial Intelligence and Neoantigens: Paving the Path for Precision Cancer Immunotherapy

Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review

Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer

Advancements in Ovarian Cancer immunodiagnostics and Therapeutics via Phage Display Technology

RNA m5C methylation: a potential modulator of innate immune pathways in hepatocellular carcinoma

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison

Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration

Editorial: Targeting key cellular signaling network for cancer chemotherapy and immunotherapy

Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer

Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission